ABSTRACT: The O-antigens, which are components of the outer membranes of Gram-negative bacteria, are responsible for the wide species variations seen in nature and are thought to play a role in bacterial virulence. They often contain unusual dideoxysugars such as 3,6-dideoxy-3-formamido-D-glucose (Qui3NFo). Here, we describe a structural and functional investigation of the protein C8J_1081 from Campylobacter jejuni 81116, which is involved in the biosynthesis of Qui3NFo. Specifically, the enzyme, hereafter referred to as WlaRD, catalyzes the N-formylation of dTDP-3,6-dideoxy-3-amino-D-glucose (dTDP-Qui3N) using N 10 -formyltetrahydrofolate as the carbon source. For this investigation, seven X-ray structures of WlaRD, in complexes with various dTDP-linked sugars and cofactors, were determined to resolutions of 1.9 Å or better. One of the models, with bound N 10 -formyltetrahydrofolate and dTDP, represents the first glimpse of an N-formyltransferase with its natural cofactor. Another model contains the reaction products, tetrahydrofolate and dTDP-Qui3NFo. In combination, the structures provide snapshots of the WlaRD active site before and after catalysis. On the basis of these structures, three amino acid residues were targeted for study: Asn 94, His 96, and Asp 132. Mutations of any of these residues resulted in a complete loss of enzymatic activity. Given the position of His 96 in the active site, it can be postulated that it functions as the active site base to remove a proton from the sugar amino group as it attacks the carbonyl carbon of the N-10 formyl group of the cofactor. Enzyme assays demonstrate that WlaRD is also capable of utilizing dTDP-3,6-dideoxy-3-amino-D-galactose (dTDP-Fuc3N) as a substrate, albeit at a much reduced catalytic efficiency.
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T he outer membranes of Gram-negative bacteria are characterized by a complex lipoglycan referred to as the lipopolysaccharide, or LPS. It can be envisioned in terms of three components: (1) lipid A, which serves to anchor the LPS to the outer membrane, (2) the core oligosaccharide, which contains sugars such as glucose, galactose, and N-acetylglucosamine as well as some seven-carbon sugars, and (3) the O-antigen or O-polysaccharide, which extends farthest away from the bacterium. Several mucosal pathogens, such as Neisseria, Haemophilus, and Campylobacter spp., lack O-polysaccharide repeating units and display considerable structural diversity in their outer core glyans. 1 These low molecular weight LPS variants are referred to as lipooligosaccharides (LOS).
The O-polysaccharides and LOS outer cores often contain unusual sugars such as colitose, paratose, or tyvelose, among others. 2 Indeed, more than 100 different di-, tri-, and tetradeoxysugars have been isolated from prokaryotic sources thus far. 3 Whereas it has been established that lipid A is a major contributor to the toxicity of Gram-negative bacterial infections, the biological role of the O-polysaccharide is less well understood. Recent studies suggest that it is important for the effective colonization of host tissues and for resistance to complementmediated killing. 4 Through the efforts of numerous laboratories, a better understanding of the manner in which unusual di-, tri-, and tetradeoxysugars are biochemically synthesized has been obtained. 5 Many are constructed around the nucleotide-linked 3,6-dideoxyhexoses, which are further modified by acetylation, amination, epimerization, and C-, N-, and O-methylation reactions. At present, there is a substantial body of literature describing these types of enzymatic modifications. There is still a paucity of structural and kinetic data on N-formyltransferases, however, that function specifically on nucleotide-linked sugars. This is somewhat surprising given that the existence of N-formylated sugars was reported back in 1985. 6 Thus far, only two biochemical studies have been described on sugar N-formyltransferases. The first was on ArnA from Escherichia coli, which catalyzes the conversion of UDP-4-amino-4-deoxy-Larabinose to UDP-4-formamido-4-deoxy-L-arabinose. 7 ArnA is a bifunctional protein, with the N-terminal domain functioning as the N-formyltransferase and the C-terminal domain catalyzing an oxidative decarboxylation reaction. The second enzyme investigated, VioF from Providencia alcalifaciens O3, catalyzes the conversion of dTDP-4-amino-4,6-dideoxy-D-glucose to dTDP-4-formamido-4,6-dideoxy-D-glucose. 8 Both ArnA and VioF use N -formyl-THF) and UMP, but details concerning the active site architecture were limited due to the absence of a bound nucleotide-linked sugar. Campylobacter jejuni 81116 (Penner serotype HS:6) has a class E LOS biosynthesis locus containing 19 genes. This locus includes 11 homologues of glycosyltransferases, one lipid A acyltransferase, and 7 genes involved in either the biosynthesis of dideoxyhexosamine residues (ddHexN) or in their modifications. 10 The basic composition of the C. jejuni LOS outer core has been proposed through mass spectrometry analysis, and it has been suggested that it contains two ddHexN residues that can be either acetylated or formylated. 10 However, the complexity and heterogeneity of the glycans produced by C. jejuni 81116 prevented the complete structural determination of the LOS outer core by NMR. In addition, two other polysaccharides are produced by C. jejuni 81116: polysaccharide A, which contains glucose, glucuronic acid, and mannose, and polysaccharide B, which contains glucose, galactose, and N-acetylglucosamine.
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Recently, we have shown that the hypothetical protein C8J_1081 from C. jejuni 81116 catalyzes the transfer of a formyl group to either dTDP-3-amino-3,6-dideoxy-D-glucose (dTDP-Qui3N) or dTDP-3-amino-3,6-dideoxy-D-galactose (dTDP-Fuc3N) as indicated in Scheme 1 (the protonation states of these substrates, when bound in the enzyme's active site, are not known). Here we report a combined structural and functional investigation of this enzyme, hereafter referred to as WlaRD. For this analysis, seven structures were determined to a resolution of 1.9 Å or better: complexes of the enzyme with N 5 -formyl-THF and dTDP, dTDP-Qui3N, dTDP-Fuc3N, or dTDP-3,6-dideoxy-3-formamido-D-galactose (dTDP-Fuc3NFo), complexes of the enzyme with N 10 -formyl-THF and dTDP or dTDP-glucose, and a complex of WlaRD with tetrahydrofolate (THF) and dTDP-3,6-dideoxy-3-formamido-D-glucose (dTDP-Qui3NFo). On the basis of these structures, site-directed mutant proteins were constructed and their kinetic parameters measured. Taken together, these studies provide, for the first time, a glimpse of a fully loaded sugar N-formyltransferase active site and reveal how enzymes in this class bind N 10 -formyl-THF.
■ MATERIALS AND METHODS
Cloning of wlaRD. The following primers were designed to amplify ORF C8J_1081 (or WlaRD, GeneBank Accession number ABV52680) from C. jejuni 81116: CJ-1030, 5′-ACGAGTTCTGCATATGATTAAAATATGTATAGCTGGA-AAAAAC-3′ (43-mer, NdeI site in italics); CJ-1032, 5′-CGGTAGTCGACTTAGTGATGGTGATGGTGATG-TAACTTATTTAATTTTTGAGCG-3′ (54-mer, SalI site in italics, 6-His tag underlined). The Phusion high fidelity DNA polymerase (New England Biolabs, Beverly, MA) and 100 ng of genomic DNA were used to obtain a PCR product that was digested with NdeI and SalI and initially cloned into pCWori+(-lacZ), giving plasmid CJV-19.
A version encoding WlaRD with a TEV-cleavable N-terminal His tag was subsequently created by utilizing CJV-19 as a PCR template. The primers used incorporated NdeI, 5′-CATATG-ATTAAAATATGTATAGCTGGAAAAAACAATATTGCC-3′, and XhoI, 5′-CTCGAGTAACTTATTTAATTTTTGA-GCGATAATTTTAAATCC-3′, restriction sites. Platinum Pfx DNA polymerase (Invitrogen) was used for amplification. The PCR product was digested with NdeI and XhoI and ligated into pET28t, a lab pET28b(+) vector that had been previously modified to incorporate a TEV protease recognition site after the N-terminal polyhistidine tag. 12 Protein Expression and Purification. The pET28t-WlaRD plasmid was used to transform Rosetta2(DE3) E. coli cells (Novagen). The cultures were grown in lysogeny broth supplemented with kanamycin and chloramphenicol at 37°C with shaking until an optical density of 0.8 was reached at 600 nm. The flasks were cooled in an ice bath, and the cells were induced with 1 mM IPTG and allowed to express protein at 16°C for 24 h.
The cells were harvested by centrifugation and disrupted by sonication on ice. The lysate was cleared by centrifugation, and WlaRD was purified utilizing Ni-NTA resin (Qiagen) according to the manufacturer's instructions. The protein was dialyzed against 10 mM Tris−HCl (pH 8.0) and 200 mM NaCl and concentrated to 11.5 mg/mL on the basis of an extinction coefficient of 1.43 (mg/mL)
. For removal of the N-terminal His 6 tag, a solution containing a 30:1 molar ratio (WlaRD:TEV protease) was allowed to digest at 4°C for 48 h. Uncleaved protein and the TEV protease were removed by passage over Ni-NTA resin. Cleaved enzyme was dialyzed and concentrated in the same manner as described above for the N-terminal tagged version.
Synthesis and Purification of the dTDP-Sugar Ligands. dTDP-Qui3N and dTDP-Fuc3N were prepared by modifications of a previously reported procedure. 13 Reactions (15 mL) containing 7 mM dTDP-glucose, 0.4 mg/mL E. coli RmlB (a 4,6-dehydratase), 1.9 mg/mL Thermoanaerobacterium thermosaccharolyticum QdtA (a 3,4-ketoisomerase), 2.9 mg/mL T. thermosaccharolyticum QdtB (an aminotransferase), 40 mM sodium glutamate, and 40 mM HEPPS (pH 8.5) were allowed to react at 37°C for 12 h to generate dTDP-Qui3N. Substitutions of Aneurinibacillus thermoaerophilus FdtA and FdtB for QdtA and QdtB, respectively, were used for the synthesis of dTDP-Fuc3N. Following a 12 h incubation, all enzymes were removed by filtration through a 10 000 MW cutoff Amicon filter. The filtered reaction mixture was then diluted 15-fold with water and loaded onto a 50 mL HiLoad 26/10 Q-Sepharose HP column. The dTDP-amino sugars were purified with a 20-column volume gradient of 0−0.2 M ammonium bicarbonate (pH 8.5) and eluted at a concentration of 0.125 M ammonium bicarbonate. All enzymes required for the syntheses of these sugars were cloned and purified in the laboratory. N 10 -formyl-THF was synthesized as previously described.
14 Specifically, N 5 -formyl-THF was first converted to 5,10-methylenetetrahydrofolate by mixing 80 mg of N 5 -formyl-THF and 160 μL of β-mercaptoethanol in 16 mL of water and adjusting the pH to 1.9 with 0.1 M HCl. The solution was incubated at room temperature for 4 h. The mixture was then converted to N 10 -formyl-THF by raising the pH to 8.5 with 1 M KOH followed by incubation at 37°C for 1 h.
For preparation of the dTDP-formylated sugars used in this investigation, 18 mL of the N 10 -formyl-THF mixture was combined with 25 mg of dTDP-Qui3N (or dTDP-Fuc3N), 10 mg of WlaRD, and 4 mL of 500 mM HEPPS (pH 8.5) and incubated overnight at 37°C. The reaction mixture was passed through a 10 000 MW cutoff Amicon filter to remove enzymes, diluted to 500 mL with water, loaded onto a 50 mL HiLoad 26/10 Q-Sepharose HP column, and eluted with a 20-column volume gradient of 0−1.5 M ammonium acetate (pH 4). The dTDP-formylated sugars eluted at a concentration of 600 mM ammonium acetate. The material was diluted, its pH adjusted to 8.5, and the sample loaded onto a second 50 mL 26/10 column for further purification. A 12-column volume gradient of 0−800 mM ammonium bicarbonate (pH 8.5) was used for this step, and the dTDP-formylated sugars eluted at a concentration of 90 mM ammonium bicarbonate. ESI mass spectrometry of the products in negative ion ionization mode gave M-1 peak masses of 574, which corresponded to the calculated masses for the dTDP-formylated sugars.
Crystallization of the WlaRD Complexes. Crystallization conditions were surveyed by the hanging drop method of vapor diffusion using a laboratory-based sparse matrix screen. The enzyme was initially tested in the absence of any added ligands or in the presence of 5 mM dTDP and 5 mM N 5 -formyl-THF. The untagged version of the enzyme yielded the best crystals from the initial screens. X-ray diffraction-quality crystals of the protein in complex with dTDP and N
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-formyl-THF were subsequently grown from precipitant solutions composed of 11−15% poly(ethylene glycol) 8000, 200 mM NaCl, and 100 mM MOPS (pH 7). The crystals belonged to the monoclinic space group C2 with unit cell dimensions of approximately a = 97.9 Å, b = 63.3 Å, c = 136.2 Å, and β = 110°. The asymmetric unit contained one dimer. Crystals of WlaRD in complex with N 5 -formyl-THF and dTDP-Qui3N, dTDPFuc3N, or dTDP-Fuc3NFo were prepared in the same manner as described above.
The WlaRD complexes with THF or N 10 -formyl-THF were generated by first transferring crystals with bound dTDP and N
-formyl-THF to a synthetic mother liquor composed of 17% poly(ethylene glycol) 8000, 300 mM NaCl, and 100 mM HEPPS (pH 8.5). The mother liquor was exchanged several times in order to remove the bound ligands. The WlaRD/ dTDP/N 10 -formyl-THF complex was then prepared by adding 5 mM dTDP, 7 mM N 10 -formyl-THF, and 0.3% β-mercaptoethanol to the mother liquor and allowing the crystals to soak for 1 day. The WlaRD/dTDP-glucose/ N 10 -formyl-THF complex was prepared in a similar manner with the substitution of 10 mM dTDP-glucose for dTDP. The dTDP-Qui3N/dTDP-Qui3NFo/THF complex was prepared by soaking the crystals in a solution containing 5 mM dTDPQui3N (substrate) and 7 mM N 10 -formyl-THF (substrate) for 12 h. The enzyme was active in the crystalline lattice such that, in one subunit, dTDP-Qui3N and THF were seen, and in the other subunit, dTDP-Qui3NFo and THF were observed.
Structural Analysis of the WlaRD Complexes. Prior to X-ray data collection at 100 K, all crystals were transferred to a cryo-protectant solution containing 20% poly(ethylene glycol) 8000, 300 mM NaCl, 18% ethylene glycol, and ligands in the same concentrations used for crystallization trials or soaking experiments. X-ray data from the cocrystals were collected at the Structural Biology Center Beamline 19-BM (Advanced Photon Source). The data were processed and scaled with HKL3000. 15 X-ray data from crystals of the complexes generated from the soaking experiments were collected in house using a Bruker AXS Platinum 135 CCD detector controlled with the APEX software suite (Bruker AXS Inc.) The X-ray source was Cu Kα radiation from a Rigaku RU200 X-ray generator equipped with Montel optics and operated at 50 kV and 90 mA. The data sets were processed with SAINT and scaled with SADABS (Bruker AXS Inc.). Relevant X-ray data collection statistics are listed in Table 1 . The first structure of WlaRD was solved via a threewavelength MAD experiment using X-ray data collected from the Structural Biology Center Beamline 19-BM. Prior to X-ray data collection, crystals of the WlaRD/dTDP/N 5 -formyl-THF complex were soaked for 24 h in a saturated solution of methylmercury acetate and subsequently were prepared for data collection at 100 K as described above. Analysis of the X-ray data with SOLVE located two mercury binding sites. 16 Initial solvent flattened protein phases were calculated with RESOLVE. 17, 18 A small region of the protein model was built near the vicinity of each mercury site, which subsequently allowed for the positioning of the local dyad in the asymmetric unit. Molecular averaging and solvent flattening resulted in a greatly improved electron density map that allowed complete tracing of the dimer. The model was then refined against X-ray data collected from the WlaRD/dTDP/N 5 -formyl-THF complex crystals. Iterative cycles of model-building with COOT and refinement with REFMAC reduced the R work and R free to 15.8% and 17.8%, respectively, from 30 to 1.4 Å resolution. 19, 20 This model was used to solve all of the other structures reported here either by difference Fourier techniques or by molecular replacement with the software package PHASER. 21 Model refinement statistics are listed in Table 2 .
Kinetic Analyses. Kinetic parameters for WlaRD were determined via a discontinuous assay using an AKTA HPLC. The reaction rates were determined by calculating the amount of dTDP-Qui3NFo (or dTDP-Fuc3NFo) produced on the basis of the peak area on the HPLC trace as measured at 267 nm. The area was correlated to concentration via a calibration curve created with standard samples that had been treated in the same manner as the reaction aliquots.
The binding parameters for the dTDP-Qui3N substrate were determined using 1 mL reactions containing 5 mM N 10 -formyl-THF, 50 mM HEPPS (pH 8.5), 0.03 mg/mL (0.94 μM) enzyme, and substrate concentrations ranging from 0.01 to Table 3 . Kinetic Parameters 2.0 mM dTDP-Qui3N. Four 250 μL aliquots were taken at time points over 4 min and quenched by the addition of 12 μL of 6 M HCL. Afterward, 200 μL of carbon tetrachloride was added, the samples were vigorously mixed and spun at 14000g for 1 min, and 200 μL of the aqueous phase was taken for subsequent analysis via HPLC. The samples were diluted with 2 mL of water and loaded onto a 1 mL ResQ column and the products quantified after elution with an eight-column volume gradient of 0−400 mM LiCl (pH 4, HCl). The binding parameters for the dTDP-Fuc3N substrate were determined using 1 mL reactions containing 5 mM N 10 -formyl-THF, 50 mM HEPPS (pH 8.5), 0.15 mg/mL (4.7 μM) enzyme, and substrate concentrations ranging from 0.1 to 6.0 mM dTDP-Fuc3N, and four samples were taken over a 10 min reaction time period for evaluation.
Plots of concentrations versus initial rates were analyzed using PRISM (GraphPad Software, Inc.) and were fitted to the equation
. Kinetic parameters are listed in Table 3 .
Site-Directed Mutagenesis. The site-directed mutant proteins N94A, H96N, and D132N were generated using the QuikChange method of Stratagene. The protein variants were expressed and purified as described above for the wild-type enzyme. Enzyme activity was assayed at protein concentrations of up to 1 mg/mL (31 μM). Even at the highest concentrations, no measurable quantities of formylated sugars could be detected after reaction times exceeding 4 h. The first structure determined in this investigation was that of the enzyme complexed with N 5 -formyl-THF and dTDP. The model was refined to an overall R factor of 15.9% at 1.4 Å resolution. A ribbon representation of the WlaRD dimer contained within the asymmetric unit is displayed in Figure 1a . The active sites are separated by over 30 Å. Dimerization results in a total buried surface area of ∼2500 Å 2 . Subunit A extends from Met 1 to Lys 271, whereas subunit B contains the last C-terminal residue, Leu 272. There are no breaks in the polypeptide chain backbones for either of the subunits. Given that the α-carbons for the two subunits superimpose with a root mean square deviation of 0.19 Å, the following discussion refers only to subunit A unless otherwise indicated.
A stereoview of subunit A is shown in Figure 1b . The overall architecture of the subunit is bilobal with the active site wedged between the two domains. The N-terminal domain, which harbors the binding pocket for the N 5 -formyl-THF cofactor, extends from Met 1 to Leu 197 and is dominated by a sixstranded mixed β-sheet flanked on one side by three α-helices and on the other by a small α-helix and random coil. The Cterminal domain, delineated by Val 198 to Lys 271, contains a four-stranded antiparallel β-sheet and an α-helix. Pro 101 adopts a cis conformation, but is not involved in the formation of the active site pocket.
Portions of the electron density map corresponding to the bound cofactor and the dTDP ligand are displayed in Figure 2a . As can be seen, the N 5 -formyl-THF cofactor adopts a curved conformation with the planes of the 2-amino-4-oxo-6-methylpterin and p-aminobenzoic acid moieties tilted at ∼90°. A close-up view of the WlaRD active site is presented in Figure 2b . The active site is quite shallow and solventaccessible. Most of the residues involved in ligand binding are provided by the N-terminal domain. The exceptions are Tyr 222 and Gln 223, which interact with the thymine ring of dTDP via stacking and hydrogen bonding interactions, respectively. Tyr 222 forms a parallel stacking interaction, whereas Phe 107, from the N-terminal domain, participates in a T-shaped interaction. Backbone carbonyl and amide groups are responsible for anchoring the 2-amino-4-oxo-6-methylpterin group of the cofactor into the active site. The formyl group lies within hydrogen bonding distance of a water molecule. There are limited interactions between the protein and the glutamyl moiety of the cofactor, which explains why the electron density is weak in this region. Both Lys 9 and Arg 192 participate in electrostatic interactions with the pyrophosphoryl group of the dTDP ligand.
The WlaRD Active Site with Bound N 5 -formyl-THF and Either dTDP-Qui3N or dTDP-Fuc3N. The proposed substrate for WlaRD is dTDP-Qui3N (Scheme 1), although our kinetic analysis shows that the enzyme also functions on dTDP-Fuc3N, albeit at a much reduced rate. Indeed, the catalytic efficiency for dTDP-Fuc3N as a substrate is reduced nearly 200-fold (Table 3) . To address the manner in which the enzyme can accommodate two substrates with altered stereochemistries about the hexose C-4′, the structures of both the WlaRD/N Figure 4a , whereas a superposition of the dTDPsugars in the WlaRD active site is presented in Figure 4b . The pyranosyl moiety of dTDP-Fuc3N is shifted slightly in the active site with respect to that of dTDP-Qui3N such that the amino nitrogen is displaced by 1 Å. This shift in the active site most likely results in the reduced catalytic efficiency of WlaRD toward dTDP-Fuc3N.
A structural alignment between WlaRD, E. coli ArnA, 9 E. coli L-methionyl-tRNA N-formyltransferase, 22 and E. coli glycinamide ribonucleotide transformylase 23 reveals three conserved residues located within the active site region: Asn 94, His 96, and Asp 132 (Figure 4a ). The N94A, H96N, and D132N sitedirected variants showed no enzymatic activity after 4 h of incubation using protein concentrations of up to 1 mg/mL (31 μM).
The WlaRD Active Site with Bound N
-formyl-THF and dTDP-Fuc3NFo. To explore the manner in which WlaRD binds an N-formylated sugar, the next goal in this study was to solve the structure of the enzyme in the presence of N 5 -formyl-THF and a formylated product sugar. All attempts to prepare a -formyl-THF/dTDP complexes correspond with a root mean square deviation of 0.21 Å. The major difference occurred around the bridge linking the bicyclic ring to the phenyl moiety of the cofactor. Due to differences in torsional angles, the C-9 carbons of the cofactors are displaced by ∼2 Å in the active site cleft (Figure 7a) .
The structure of WlaRD in complex with N 10 -formyl-THF and dTDP-glucose was solved to 1.6 Å resolution. Shown in Figure 6b is the electron density corresponding to these two ligands. Although the density for the dTDP-glucose was welldefined, that corresponding to the phenyl and glutamyl groups of the cofactor was quite weak. This disordering of the phenyl and glutamyl moieties was also observed in the structural analysis of E. coli glycinamide ribonucleotide transformylase. 23 A superposition of the WlaRD active sites with bound N 10 -formyl-THF and dTDP-glucose versus N
-formyl-THF and dTDP-Qui3N is displayed in Figure 7b . The α-carbons for the two models superimpose with a root mean square deviation of 0.13 Å. The active site of WlaRD accommodates the presence of the C-6′ hydroxyl group on dTDP-glucose by shifting the hexose moiety out of the binding pocket. As a consequence, its C-3′ hydroxyl group lies at ∼3 Å from where the C-3 amino group of dTDP-Qui3N is located.
For the final structure determined in this investigation, WlaRD crystals were soaked in solutions containing N 10 -formyl-THF and dTDP-Qui3N with the goal of trapping the reaction products in the active site. In subunit A, THF and dTDP-Qui3N were observed. In subunit B, however, the products THF and dTDPQui3NFo were present as indicated by the electron density shown in Figure 6c difference in rotation about the bridge that links the bicyclic ring to the phenyl moiety of the cofactor (Figure 7a ). The structure of WlaRD with bound N 10 -formyl-THF and dTDP-glucose showed that the WlaRD active site is large enough to accommodate a hydroxyl group at the C′-6 position of a pyranosyl ring, albeit by shifting it out of the active site (Figure 7b ).
Clearly the most significant WlaRD structure solved was that with the bound products THF and dTDP-Qui3NFo (Figure 7c ). This model represents the active site following catalysis. By superimposing the WlaRD structures in complex with N 10 -formyl-THF/dTDP and THF/dTDP-Qui3N, it was also possible to generate a model of the active site before catalysis proton from the substrate's amino group as it attacks the formyl carbon of the cofactor, resulting in a tetrahedral transition state. 23 Although both His 96 and Asp 132 in WlaRD could possibly function in such a role, the imidazole ring of His 96 appears to be in a more suitable orientation for proton abstraction (Figure 8 ). The fact that Asp 132 is within hydrogen bonding distance of the formyl oxygen of the sugar product suggests that it is protonated after catalysis. Its protonation state before catalysis is unknown. Importantly, mutation of either His 96 or Asp 132 resulted in an inactive protein under the assay conditions employed. When Asn 94 was mutated to an alanine, all activity was lost. As suggested for glycinamide ribonucleotide transformylase, it is possible that this conserved asparagine residue plays a role in the formation of an oxyanion hole required to stabilize the negatively charged oxygen of the tetrahedral transition state.
In conclusion, the series of high-resolution structural analyses presented here has provided a detailed description of the molecular architecture of WlaRD and serves as a paradigm for bacterial N-formyltransferases that function on nucleotide-linked sugars. 
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